Abstract. The fibronectin receptor, ,5fll, has been shown to be required for fibronectin matrix assembly and plays an important role in cell migration on fibronectin. However, it is not clear whether other fibronectin binding integrins can take the place of et5B1 during matrix assembly and cell migration. To test this, we expressed the human ~v subunit in the CHO cell line CHO-B2 that lacks the o~5 subunit. We found that the human oev combined with CHO cell/31 to form the integrin otvB1. Cells that expressed otv/31 attached to and spread well on fibronectin-coated dishes, but did so less well on vitronectin-coated dishes. This, along with other data, indicated that c~v/31 functions as a fibronectin receptor in CHO-B2 cells. The otv/31-expressing cells failed to produce a fibronectin matrix or to migrate on fibronectin, although the same cells transfected with or5 do produce a matrix and migrate on fibronectin. The affinity of the avfll-expressing cells for fibronectin was fourfold lower than that of the ,5fll-expressing cells. In addition, otv/31 was distributed diffusely throughout the cell surface, whereas oe5/31 was localized to focal adhesions when cells were seeded onto fibronectincoated surfaces. Thus, of the two fibronectin receptors, av/31 and o~5/31, only ot5/31 supports fibronectin matrix assembly and promotes cell migration on fibronectin in the CHO-B2 cells. Possible reasons for this difference in the activities of av/$1 and o~5/31 inelude the lower affinity of ~,v/~ 1 for fibronectin and the failure of this integrin to localize in adhesion plaques on a fibronectin substrate. These results show that two integrins with similar ligand specificities and cell attachment functions may be quite different in their ability to support fibronectin matrix assembly and cell motility on fibronectin.
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T HE pericellular fibronectin matrix plays an important role in cell adhesion, migration, and growth control (Hynes, 1990; Ruoslahti and Giancotti, 1990) . The main receptor for fibronectin in many cells is the ot5/31 integrin (Pytela et al., 1985a; Ruoslahti, 1991) . This integrin not only attaches cells to the fibronectin matrix, hut also regulates the formation of this matrix. That ot5/31 participates in matrix formation is clear from a number of observations; antibodies against a5/31 inhibit matrix formation (Akiyama et al., 1989; , lowering the expression of ot5/~l can eliminate matrix deposition, whereas reintroduction of the integrin restores matrix deposition (Wu, C., J. S. Bauer, R. L. Juliano, and J. A. McDonald, personal communication) . Moreover, the amount of matrix deposited is proportional to the amount of ot5~1 on the cells; overexpression of ot5/~ 1 from transfected eDNA increases the deposition of fibronectin matrix (Giancotti and . Malignant transformation often reduces the expression of the ot5/~l integrin and this is accompanied by a loss of fibronectin matrix around the transformed cells (Plantefaber and Hynes, 1989) . The matrix loss is thought to contribute to the migratory and invasive properties of such cells. In fact, overexpression of the c~5/31 integrin in CHO cells drastically restricts the ability of these cells to migrate and makes them non-tumorigenic (Giancotti and , whereas elimination of the integrin has the opposite effect (Schreiner et al., 1991) .
To better understand the role of fibronectin receptors in fibronectin matrix assembly and cell motility, we tested whether a fibronectin receptor other than ct5/31 could function in these processes. In addition to ot5/31, other integrins have also been found to bind to fibronectin including: tx3/31, t~4t31, avfll, ctv/33, and otv/36 (Ruoslahti, 1991; Busk et al., 1992) . Of these integrins, otv/31 was of particular interest because, like ot5/31, it binds to the Arg-Gly-Asp (RGD) site in fibronectin (Vogel et al., 1990) . We engineered an ,v/31-expressing cell line by using a CHO cell line that was selected to be essentially devoid of the ct5 subunit and that has lost its ability to attach to fibronectin (Schreiner et al., 1989) , to migrate on fibronectin (Bauer et al., 1992) , or to form a fibronectin matrix (Wu, C., J. S. Bauer, R. L. Juliano, and J. A. McDonald, personal communication) . These bio-logical activities are restored, however, by transfecting the cells with the human ct5 subunit (Bauer et al., 1992 ; Wu, C., J. S. Bauer, R. L. Juliano, and J. A. McDonald, personal communication). In this report we find that expressing the avfll integrin by transfection of the human otv into the ot5-deficient cells enabled the cells to attach to fibronectin, however, in contrast to a5fll, avB1 supported neither fibronectin matrix assembly nor cell migration on fibronectin.
Materials and Methods

Materials
c~-MEM and Geneticin (G418) were purchased from GIBCO BRL (Gaithersburg, MD), methionine-deficient MEM from ICN Biomedicals (Costa Mesa, CA), FBS from Tissue Culture Biologicais (Tulare, CA), and Glutamine Pen-Strep from Irvine Scientifc (Santa Ana, CA). Iodo-Gen was obtained from Pierce Chemical Co. (Rockford, IL). Acrylamide was purchased from Bethesda Research Laboratories (Gaithersburg, MD). Microtitration multi-well plates were obtained from Flow Laboratories (McLean, VA). Human plasma fibronectin was from the Finnish Red Cross and vitroneetin from Telios Pharmaceuticals (La Jolla, CA). The ll0-kD fibronectin fragment containing the cell binding domain was made as previously described (Pierschbacher et al., 1981) . Peptides GRGDSP and GRGESP were synthesized at the Protein Chemistry Laboratory of the La Jolla Cancer Research Foundation (La Joila, CA). All other reagents were acquired from Sigma Immunochemicals (St. Louis, MO).
An o~5fll-deflcient CHO cell line (B2), which expresses ",,2% of the wild type level of otSfll (Schreiner et al., 1989) was used for transfectiun experiments. CHO-B2 ceils transfected with the a5 integrin subunit (1132/o27 clone) have previously been described (] Bauer et al., 1992) . The B2/ot27 clone expressed 3.4 times more ct5fll than the wild type CHO cell line. The CHO-B2 cells were grown in ct-MEM with 10% FBS and 2.5/~g/ml Glutamine Pen-Strep. The B2/a27 cells were grown in the same medium containing 400/~g/ml G-418.
Transfection of av cDNA
A 4.2-kb human integrin ~ eDNA (Suzuki et al., 1987) , which includes the entire otv coding sequence, was cloned into the mammalian expression vector peDNA1/neo (Invitrogen, La Joila, CA; Felding-Habermann et al., 1992) . The plasmid DNA was introduced into B2 cells by calcium phosphate transfeetion (Cben and Okayama, 1988) . Cells were split 2 d after transfection and grown in medium containing 400 #g/mi G418 for 10 more days. The G418-resistant colonies were cloned and expanded, and avexpressing clones were identified by immunoblotting of cell extracts (Giancotti and ) with anti-human c~v mAb 137 (Freed et al., 1989) . The parental vector pcDNAl/neo was also transfected into B2 cells to generate control clones.
Integrin Analysis
Integrin expression in the B2 cells and in the transfectants was evaluated by surface iodination of cells and immunoprecipitation with anti-integrin antibodies (Pytela et ai., 1985a,b; Vogel et al., 1993) . Cells were lysed in RIPA buffer (1% NP-40, 0.5% DOC, 0.1% SDS, 150 mM NaCl, 50 mM Tris, pH 8.0) for 30 rain on ice. After a 20-rain centrifugation at 16,000 g, supernatants were used for immunoprecipitation. The antibodies used were mAb P1D6 (anti-human ~5; Wayner et al., 1988), mAb 147 (anti-human ,v; Freed et ai., 1989) , an anti-a5 cytoplasmic domain polyclonal antibody (Giancotti and , an anti-fl3 cytoplasmic domain polyclonat antibody, and an anti-av cytoplasmic domain polyclonal antibody (Vogel et al., 1993) . mAb DH2 (anti-ganglioside GM3; Kojima and Hakomori, 1991) and an unrelated polyclunal antibody were used as controls.
The level of expression of integrins was measured by FACS analysis. B2/cl, B2/ot27, and B2/v7 ceils were detached with 5 mM EDTA in PBS. After three washes with cold PBS, ceils were stained with anti-av mAb 147 or anti-a5 mAb P1D6 followed by a FITC-conjugated goat anti-mouse IgG (Sigma Immunochemicals) staining. Cells were fixed with ethanol and analyzed with a FACStar machine (Bectun Dickinson Immunocytometry Systems, Mountain View, CA).
Cell Attachment Assay
Cell attachment to coated fibronectin and vitronectin was assayed in microtiter plates as previously described (Pytela et ai., 1985b; ). Quantitation of cell attachment was achieved by staining cells with 0.5% crystal violet in 20% methanol, washing cells, and then eluting the dye with 0.1 M sodium citrate, pH 4.2, and measuring the absorbance at 600 am.
Integrin AJffnity Measurement
Iodination of the cell-binding 110-kD fibronectin fragment was done as described elsewhere (Morla and Ruoslahti, 1992) . The specific activity of the radioiodinated ll0-kD fragment was typically 1.6 × 10 I° t~Ci/mmol. The binding of the 125I-l10-kD fragment to cells in suspension was performed essentially as previously described (Akiyama and Yamada, 1985) . Briefly, cells were detached with 10 mM EDTA in PBS, washed three times with ~-MEM and once with binding buffer (1% BSA, 25 mld Hepes, pH 7.3, in a-MEM). Cells (5-10 x 107 cells/ml) were incubated with lz~I-110-kD fragment (2 x los #Ci/ml), in a total volume of 150 #1 of binding buffer, for 1 h at room temperature with constant shaking. Specific binding was determined by competing with unlabeled 110-kD fragment. After binding, the cells were centrifuged for 25 s at 14,000 g and were washed twice with 500 #1 ice-cold binding buffer. The amount of I~I-ll0-kD protein remaining in the cell pellet was measured. The binding data were analyzed by using the Ligand program (National Institutes of Health, Bethesda, MD) for the Macintosh computer.
Cell Motility Assay
Cell motility in the presence of fibronectin was measured using a modified Boyden chamber (NeuroProbe, Cabin John, MD) as previously described (Albini et al., 1987) with slight modifications. The undersurface of 10-~m-pore polycarbonate membrane filter (Foretics, Livermore, CA) was first precoated with 10 t~g/ml of fibronectin. Lower chambers were filled with a-MEM containing 0.1% BSA and 10 t~g/mi of fibronectin. Cells (1 × l0 s) were added to the upper chambers in the same media described above except without fibronectin. The cells were incubated at 370C for 3, 6, 12, and 24 h and then the membranes were fixed in methanol and cells were stained with 0.5% toluidine blue in 3.7% formaldehyde. The cells on the upper surface of the membrane were removed, the membranes were mounted on glass slides and the number of ceils that had migrated to the lower surface were counted. Four high-magnification microscopic fields were counted per well and all experiments were performed in quadruplicate. Migration results are expressed in terms of the average number of cells/high-magnification microscopic field (HMMC) I.
Matrix Assembly Assay
Matrix assembly assays were carded out by using 12SI-labeled fibronectin as described previously (McKeown-Longo and Mosher, 1985; Morla and Ruoslahti, 1992) .
Immunofluorescence
For fibronectin matrix staining, ceils were grown to confluence on coverslips, washed, and fixed in 3.7% parafonnaldehyde, 10 mM sucrose in PBS (pH 7.4) for 30 rain. Cells were then stained with rabbit anti-mouse fibronectin antiserum for 2 h followed by rhodamine-labeled goat antirabbit IgG secondary antibody (Cappel, West Chester, PA). For integrin staining, cells were fixed for 10 min, permeabilized with 0.5% NP-40 in PBS for 15 min, and then stained with either anti-vinculin, anti-oo/, anti-a5, or anti-~ cytoplasmic domain antisera followed by rhodamine-labeled secondary antibodies. After antibody treatments, coverslips were mounted onto slides with 200 mM n-propyl gallate, 50% glycerol in PBS.
Results
Expression of av in CHO Cells
To test the role of the a~cfll integrin in fibronectin matrix as- 6, 9, 12, and 15) , or a control mAb to ganglioside GM3 (lanes 1, 4, 7, 10, and 13) . The immunoprecipitated proteins were analyzed by SDS-PAGE under non-reducing conditions. The following cell lines were analyzed; the parental B2 cell line (lanes 1-3); a parental vector transfected control cell line, B2/cl (lanes 4-6); an tx5-transfected cell line, B2/ot27 (lanes 7-9); and two txv-transfected cell lines, B2/v7 (lanes 10--12) and B2/v12 (lanes 13-15). (B) Surface-labeled cell lysates were immunoprecipitated with anti-ix5 cytoplasmic domain antiserum (lanes 2, 6, 10, 14, and 18) , anti-txv cytoplasmic domain antiserum (lanes 3, 7, 11, 15, and 19) , anti-B3 cytoplasmic domain antiserum (lanes 4, 8, 12, 16, and 20) or a control antiserum prepared against an unrelated antigen (lanes 1, 5, 9, 13, and 17) . The immunoprecipitated proteins were analyzed by SDS-PAGE under non-reducing conditions. The cell lines examined were B2 (lanes 1-4), B2/cl (lanes 5-8), B2hx27 (lanes 9-12), B2/v7 (lanes 13-16), and B2/v12 (lanes 17-20) . At the exposure level shown here, the human ix5 subunit (lane 8 of A and lane 10 of B) is not readily discernible.
sembly and cell motility on fibronectin, a full-length cDNA of human av was introduced into an ot5B 1-deficient CHO cell line (B2; Schreiner et al., 1989) . G418-resistant clones were picked and screened for ~v expression by immunoblotting. Two clones that expressed high levels of human otv (B2/v7 and B2/v12) were chosen for further study. The human txv associated with the endogenous B1 to form the txvB1 integrin in these ceils (Fig. 1 A, lanes 12 and 15) . No otv/$1 was detected in the parental B2 cell line, or in the B2/tx2 7 cell line which was transfected with human or5 (Fig. 1 B, lanes 3, 7 , and 1/), even though the I32 cell line (and the transfectants derived from this cell line) expresses an endogenous we subunit. The endogenous o~v is associated with a/3 subunit that is likely to be/~5, since it was the size of/5 3 or/55, and it was not immunoprecipitated by antibodies to/33 (Fig. 1 B,  lanes 4 and 8) . Also, we have found that B2 cells express/$5 mRNA but no detectable/53 mRNA (not shown). It seems that txv becomes associated with /31 in these cells only when the av concentration exceeds that of/55 as is the case with the otv transfectants.
Immunoprecipitation with anti-/51 antibodies failed to reveal any/31-containing integrins in B2 cells. However, anti-B1 immunoprecipitated ot5~l from B2/ct27 and c~v/51 from B2/v7 and B2/v12 cells (data not shown). These results confirmed that the human otv associated with the hamster/51 in the uv transfectants.
To provide an estimate of the relative amount of ct5/31 and o~v~l expressed in the ix5-and otv-transfected cell lines, B2/cl, B2/v7, B2/v12, and B2/ct27 cells were subjected to FACS analysis with mAb 147 (anti-human txv) and mAb P1D6 (anti-human ct5). The results showed that the apparent level of ctv/$1 expressed in B2/v12 and B2/v7 cells was approximately twofold higher than the level of ct5/31 expressed in B2/a27 cells (results obtained with B2/v7 and B2/ot27 are shown in Fig. 2 ).
av/51 Is a ~bronectin Receptor in CHO Cells
The av~l integrin has been reported to be a fibronectin receptor (Vogel et al., 1990) , a vitronectin receptor (Bodary and McLean, 1990) , and a receptor for type I collagen (Dedhar and Gray, 1990) .
The B2/v7 and B2/v12 cells attached to and spread on fibronectin, while the parental B2 cells did not. Figs. 3 and 4 A show the results with the B2/v7 cells. In contrast, the parental B2 cells attached to and spread on vitronectin better than the av-transfected cells (Figs. 3 and 4 B) . These results indicate that fibronectin rather than vitronectin is the ligand of txv/31 in these CHO cells.
The attachment of the B2/v7 cells to fibronectin was completely inhibited by both anti-otv/$3 and anti-ot5~l polyclonal antisera, while a preimmune serum had no effect (Fig. 5 A) . The anti-o~v/33 antiserum did not inhibit the attachment of the B2/ot27 (ot5/51 positive) cells to fibronectin (Fig. 5 B) , thereby demonstrating the specificity of the inhibition of the B2/v7 cells. GRGDSP peptide at 1 mg/ml also fully inhibited the attachment of otv-transfected cells to fibronectin, while the same concentration of GRGESP peptide had no effect (Fig. 5 A) . These results indicate that the txv-transfected cells attached to fibronectin by using the otvB1 integrin and that the RGD sequence is the binding site on fibronectin for otv/51.
cxv/51 Cannot Replace cx5/51 in Fibronectin Matrix Assembly
We next examined whether otvB1 could replace ot5B1 in fibronectin matrix assembly. Cell monolayers were incubated with ~5I-labeled fibronectin for 1 h (binding of fibronectin to cell monolayers) or 24 h (matrix deposition), and the amount of radiolabeled fibronectin that was bound to the cell monolayer or incorporated into a detergent insoluble matrix was measured (McKex~n-Longo and Mosher, 1985) . The B2/ot27 cells were the most efficient at both binding fibronectin from the medium (Fig. 6 A) , and at depositing fibronectin into the matrix (Fig 6 B) and deposited into the matrix approximately 10-fold more fibronectin than the parental B2 cells, and approximately fivefold more than the txv transfectants, the B2/v7 and B2/v12 (Fig. 6 B) .
Immunofluorescence with anti-fibronectin antibodies (Fig.  7) showed fibronectin fibrils only on B2/a27 cells. To exclude the possibility that the ditferences in matrix assembly would be due to differences in fibronectin expression in B2/v7 and B2/ot27 cells, the amount of fibronectin synthesis was measured by labeling cells with [35S]methionlne and immunoprecipitating medium and cell layer samples with an anti-fibronectin antiserum. Both cell lines synthesized equivalent amounts of fibmnectin, however, proportionately more of the fibronectin was found associated with the cell layer in B2/ot27 cells than in B2/v7 cells (results not shown). Thus the immunofluorescenee with anti-fibmnectin antibod- 
~v# l-expressing CHO-B2 Cells Migrate Poorly on Fibronectin
Previous studies have shown that the rate of cell migration on fibronectin is correlated to the level of c~5~1 fibronectin receptor on the cells (Bauer et al., 1992) . As shown in Fig.  8 , B2/c~27 cells migrated significantly better than B2/cl cells did on fibronectin. B2/v7 and B2/v12 cells also migrated better than B2/cl cells, however their rate of migration was sixto ninefold lower than that of B2/c~27 cells. Thus, while c~5~1 and c~v~l both function as fibronectin receptors, o~5~1 supports cell migration on fibronectin to a greater extent than does cw#l. B2/cl, B2/v7, B2/v12, and B2/c~27 did not migrate well on collagen type I, collagen type IV, or laminin. Moreover, otv expression in B2 cells did not restore vitronectin migration, as does o~5 expression (Bauer et al., 1992 ). Since we have not found a non-fibronectin matrix protein to which the cells adhere well, we are not able to determine the migratory ability of the otv-transfected cells on other substrates.
Binding Affinities of cxv~ l and 0t5131
To explore possible reasons for the lack of matrix deposition and migratory ability in the ow/~l expressors, we determined the affinities of otv#l and ot5/~l for fibronectin by measuring the binding of a l~5I-labeled ll0-kD cell-binding fibronectin fragment to the B2/v7 and B2/ot27 cells in suspension. The half-maximal binding of the '2q-ll0-kD fragment to B2/v7 and B2/o~27 cells was reached at 20 min, with maximal binding at 60 min (data not shown), which agrees with previous results (Akiyama and Yarnada, 1985) . Analysis of the binding of the ~2q-ll0-kD fragment to B2/v7 cells indicated one class of binding sites with a dissociation constant of 2.4 + 1.4 x 10 -7 M (Fig. 9 A) , and with 3.5 + 2.4 x 104 binding sites per cell. The binding results obtained with B2/ot27 cells were also consistent with one class of binding sites, with a dissociation constant of 5.7 + 1.7 x 10-8 M, and 1.8 + 0.5 x 104 binding sites per cell (Fig. 9 B) . The results indicate that o~v/~l has a fourfold lower affinity for the ll0-kD fragment than ~5/31, however, the B2/v7 cells had approximately twofold more available binding sites than the B2/ot27 cells for the ll0-kD fragment.
c~vB l and ~5131 have Different SubceUular Localizations
Immunofluorescence showed that in B2/o~27 cells seeded onto fibronectin, the or5, txv, and/51 integrin subunits were localized to structures identical to focal contacts, as visualized with antibodies to vinculin (Fig. 10, right) . In B2/v7 cells ( Fig. 10 , left) and B2/v12 cells (not shown), the otv and /51 subunits were predominantly diffusely localized and not found in focal contacts, although some otv and B1 staining can occasionally be found in focal contact-like structures.
No specific staining was detectable with anti-or5 antibodies on B2/v7 or B2/v12 cells, due to the very low level of or5 in these cells. Thus, while ot5/51 localized to focal contacts in B2/tx27 cells, otv/51 was diffusely localized in B2/v7 and B2/v12 cells, indicating that these two integrins occupy different subcellular localization in B2 cells.
Discussion
We have found that transfecting the human o~v integrin subunit into CHO cells which are deficient in the or5 subunit results in the expression of a human av hamster/51 integrin, and that this integrin functions as a fibronectin receptor and not a vitronectin receptor in these cells. Moreover, although ,v/51 and a5/51 are both fibronectin receptors and bind to the RGD site, c~,/51 could not substitute for ot5/51 in fibronectin matrix assembly or in cell migration on fibronectin.
In agreement with earlier results from our laboratory (Vogel et al., 1990) , the present study indicates that the av/51 integrin is a fibronectin receptor. For example, the ,v/51 expressing cells (B2/v7) attached to and spread on a fibronectin substratum whereas the parental B2 cells did not. In addition, the attachment of B2/v7 cells to fibronectin was inhibited by both an anti-otv/53 antiserum and an anti-ix5/51 antiserum, which is in agreement with the conclusion that otv/51 mediated the attachment. Also, B2/v7 cell binding to fibronectin was inhibited by RGD, which has been shown to be the binding site for txvBl (Bodary and McLean, 1990; Vogel et al., 1990) . Our results do not support the previously reported designation of txvB1 as a vitronectin receptor (]30-dary and McLean, 1990) ; the attachment of the ow/51 expressing B2/v7 and B2/v12 cells to vitronectin was actually lower than that of their parental counterpart. However, since the integrin specificities of fibronecfin and vitronectin are very similar (Pytela et al., 1985b) Log Total ~,I) Figure 9 . Displacement carves and Scatchard plots for the binding of lz~I-110-kD fibronectin fragment to B2/v7 and B2/ot27 ceils. B2/v7 ceils (,4) and B2/ot27 cells (B) were incubated with t2~I-ll0-kD fragment plus various concentrations of unlabeled 110-kD fragment for 1 h. The amount of labeled ll0-kD fragment bound to the ceils was quantitated, and the displacement curves and Scatchard plots (insets) were generated as described in Materials and Methods.
vitroneetin binding by ow/31 may occur in other cells and other experimental conditions. We conclude that otvB1 is a fibroneetin receptor when expressed in ot5-defieient CHO cells. A previous study suggested that some/51 integrin other than ot5/~l may also be involved in fibronectin matrix formation . Our results show that although ow#l is a fibronectin receptor that binds to the RGD cell attachment site on fibronectin, t~v/~l cannot substitute for ~5#1 during fibronectin matrix assembly. Another property in which the ot5#l-and av#l-expressing cells differ is in their ability to migrate on fibronectin. Our results, and previous work (Bauer et al., 1992) , indicate that the ot5/31 integrin allows CHO cells to migrate on fibronectin. We found, however, that the otv#l integrin supported migration to a much lesser extent. Thus, the cells expressing c~v/31 are deficient both in the ability to assemble a fibronectin matrix and in their ability to migrate on fibronectin, when compared to the or5# 1-expressing cells.
One possible reason for the differences in matrix assembly and migratory ability of the cells expressing ot5/31 and ow/~l is that tzv/31 has a lower affinity for fibronectin than does ot5/~l. It is possible that while the affinity of o~v/31 is sufficient Figure 10 . Immunofluorescence detection of integdns and vinculin in av and c~5 transfectants. B2/v7 (left) and B2/c~27 (right) cells were seeded onto fibronectin-coated coverslips for 3 h at 37°C. Cells were processed for indirect immunofluorescence with either anti-vinculin antibodies, anti-otv cytoplasmic domain antibodies, anti-or5 cytoplasmic domain antibodies, or anti-#l cytoplasmic domain antibodies as indicated in the figure. Bar, 5 #m.
to allow for cell attachment and spreading on fibronectin, it is too low to support either matrix assembly or cell migration on fibronectin.
Another reason for the inability of ow#l to support matrix assembly and cell migration, that is not mutually exclusive with the low affinity, may be that ctv#l does not localize to focal contacts in cells that are attached to fibronectin. Previous studies have suggested that integrins interact with the cytoskeleton at focal contacts (Chen et al., 1985) . The ot5/31 and otv/~3 integrins have been implicated in interactions with the actin cytoskeleton, since these integrins localize to focal contacts when fibroblasts spread on either an RGD peptide, vitronectin or fibronectin (Singer et al., 1988) . In our study, when cells were seeded on fibronectin, an otv-containing integrin (most likely av#5, results not shown) localized to focal contacts only when ot5/31 was present in the cell. Little otv-or/~l-contalning integrin staining was found in focal contacts in the ow-transfected cells, even though these cells had focal contacts. Since interaction with cytoskeletal proteins may determine whether an integrin localizes to focal con-tacts, it is possible that otv/31 does not interact with cytoskeletal proteins in the same manner as o~5/51. The tx, v and or5 transfectants may be useful tools for exploring questions other than matrix assembly, such as the interactions of integrins with cytoskeletal and focal contact proteins.
Finally, it may be that the tx5/51 integrin has some secondary effect on the fibronectin molecule beyond the binding of the RGD sequence, and that this effect is needed for matrix assembly and migration. A possible candidate for a mediator of such an effect is a secondary binding site discovered recently in integrins (Vogel et al., 1993) . This binding site is directed toward sequences that are rich in basic amino acids and has a distinct specificity in different integrins.
In summary, our results demonstrate that av/31 can function as a fibronectin receptor but is not able to support either fibronectin matrix assembly or cell migration on fibronectin in CHO cells. This reveals an unexpected difference in the functions of two fibronectin binding integrins in fibronectin matrix assembly and cell migration on fibronectin. Studying this specificity should help us to understand the process of matrix assembly and cell motility in greater detail.
